EACS Webcast & Video Podcast of the 11th European AIDS Conference / EACS powered by - MULTIWEBCAST - State-of-the-art Webcast Services

SIGN IN | REGISTER NOW! | INVITATION CODE

11th European AIDS Conference / EACS

LIST OF PRESENTATIONS

OTHER WEBCASTS

Webcasted Presentations

BROWSE BY:

ALL PRESENTATIONS AT A GLANCE

PODCAST/VODCAST

Use this index to quickly access speakers by name.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

View all the presentations from an individual speaker by finding his/her name in the alphabetical listing below.

A

Jose Ramon Arribas
	Lopinavir-ritonavir Monotherapy vs Lopinavir-ritonavir and Two Nucleosides for Maintenance Therapy of HIV. Ninety-six Week Results of a Randomized, Controlled, Open Label, Clinical Trial (OK04 Study) 2007-10-25 - English

Jose Ramon Arribas
	Will new drugs change treatment paradigms? 2007-10-27 - English

Elisabeth Aslangul
	A prospective, randomized, open label trial comparing the efficacy and safety of rosuvastatin versus pravastatin in HIV-infected subjects receiving ritonavir boosted PI with lipid abnormalities. 2007-10-26 - English

Bertran Auvert
	Male Circumcision 2007-10-26 - English

Alex Azwa
	The Natural History of Acute Hepatitis C (AHC) in HIV Co-infected Individuals . A European Collaborative Study 2007-10-26 - English

B

Claudia Balotta
	Trends in Transmitted Drug Resistance among Different Routes of Infection and Seroconverters as Defined by an Antibody Avidity Assay 2007-10-25 - English

Sanjay Bhagani
	Clinical Case 2 - Hepatitis C 2007-10-26 - English

Marta Boffito
	Pharmacokinetics (PK) ofatazanavir/ritonavir (ATV/r) once daily (OD) and lopinavir/ritonavir (LPV/r) twice daily (BD) and ODover 72 hours following drug intake cessation 2007-10-26 - English

C

Sandra A. Calarota
	Antigen-specific T Lymphocytes with High Proliferative Capacity Inversely Correlate with Viral Replication in Chronically Untreated HIV-1-infected Individuals 2007-10-25 - English

Alexandra Calmy
	Incidence of Nevirapine-associated Hypersensitivity Reactions in Once Daily versus Twice Daily Regimen. A Collaborative Cohort Study 2007-10-25 - English

Jacqueline Capeau
	Does HIV Therapy Affect Normal Aging? 2007-10-27 - English

Erika Castro
	High rates of primary resistance to NNRTI among patients with HIV-1 non-B clades infection in Switzerland 2007-10-26 - English

Anna Maria Cattelan
	Nevirapine in Combination with Atazanavir/Ritonavir as a Nucleoside-sparing Regimen in HIV-infected-antiretroviral Experienced Subjects with Sustained Virologic Suppression (NEVATA Study) 2007-10-25 - English

Nathan Clumeck
	Which Indicator Diseases? 2007-10-25 - English

Nathan Clumeck
	Introduction to HIV Treatment Guidelines 2007-10-26 - English

D

Edwin DeJesus
	Virologic Suppression Is Maintained After Change To Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (EFV/FTC/TDF) vs. Continuation of Current Antiretroviral Therapy: Study 073 -Results of 24-week Interim Efficacy Analyses 2007-10-26 - English

Diane Descamps
	Mutations Associated with Virologic Response to Darunavir/ritonavir in HIV-1-infected PI-experienced Patients 2007-10-25 - English

Stephanie Dominguez
	Long-term Impact of Interferon (IFN)-based Therapy on Liver-related Decompensation, Hepato-Cellular Carcinoma (HCC) and Liver Death in HIV/HCV Co-infected Patients: A Retrospective Cohort Study (Intercept) 2007-10-26 - English

E

Vicente Estrada
	The Pro12Ala Polymorphism of Peroxisome Proliferator Activated Receptor Gene y-2 (PPAR Gamma-2) is Associated with Increased Insulin Sensitivity in HIV-infected Patients on Antiretroviral Therapy 2007-10-25 - English

F

Gerd Fatkenheuer
	Efficacy and Safety of Maraviroc (MVC) Plus Optimized Background Therapy (OBT) in Viraemic, Antiretroviral Treatment-Experienced Patients Infected with CCR5-Tropic (R5) HIV-1 in Europe, Australia and North America (MOTIVATE 2): 48-Week Results 2007-10-25 - English

Robert Fieldhouse
	HIV Is My Disease 2007-10-25 - English

Martin Fisher
	Switching from Combivir[CBV] (AZT/3TC) to Truvada [TVD] (Tenofovir DF/FTC) Maintains Viral Suppression, Prevents and Reverses Limb Fat Loss, and Improves Biochemical Parameters: Results of a 48 Week Randomised Study 2007-10-25 - English

Philippe Flandre
	Prognostic Factors of Virological Success in Antiretroviral-naïve Patients Receiving LPV/r Monotherapy in the MONARK Trial 2007-10-25 - English

G

Brian Gazzard
	Use of Indicator Diseases to Optimize Testing 2007-10-25 - English

Nicola Gianotti
	Boosted or Unboosted Atazanavir as Simplification of Lopinavir/r-containing Regimens 2007-10-25 - English

Steven Grinspoon
	Long-Term Safety and Efficacy of Tesamorelin (TH9507), a Growth Hormone-Releasing Factor (GRF) Analogue, in HIV-Infected Patients with Abdominal Fat Accumulation 2007-10-26 - English

Huldrych Günthard
	How to Best Sequence PI's 2007-10-25 - English

H

Thomas Harrer
	A Randomized, Controlled, Phase II Study with an MVA-nef Vaccine in HIV-1 Infected Patients Followed by Structured Treatment Interruption (STI) 2007-10-26 - English

Bernard Hirschel
	Growing Old with HIV 2007-10-26 - English

Christian Hoffman
	Cancer and HIV: What Does the Future Hold? 2007-10-27 - English

I

Corinne Isnard Bagnis
	The ageing patient with HIV... Assessing and managing renal disease in HIV 2007-10-27 - English

K

Ole Kirk
	Predicting the CD4 Slope in Patients Starting cART after 1st January 1999 2007-10-26 - English

Christina Kreuzberg
	Clinical Consequences of Discordant Immuno-/ Virological Responses in Patients Initiating HAART at Severe Immunodeficiency 2007-10-26 - English

L

Joep Lange
	HIV Treatment and Prevention: Facing the Future 2007-10-24 - English

Joep Lange
	Pre-exposure Prophylaxis(PrEP): State-of-the-art 2007-10-26 - English

Emilie Lanoy
	Improvement of Survival after a Neurological AIDS Defining Event over Time 2007-10-25 - English

María López-Diéguez
	Morbidity and Mortality in HIV Infected Patients with Compensated and Decompensated Cirrhosis: Prospective Cohort of 373 Patients 2007-10-26 - English

Jens Lundgren
	Should HIV Treatment Be Started Sooner? 2007-10-25 - English

M

Weerawat Manosuthi
	Survival and Risk of Death among HIV-infected Patients who Diagnosed Cryptococcal Meningitis with/without Antiretroviral Therapy in a Resource-Limited Settings 2007-10-25 - English

Esteban Martinez
	Triggers to Modifying Treatment 2007-10-25 - English

Esteban Martinez
	Clinical Case 2 - Naive ART Patient with Marginal Increased Risk of CVD 2007-10-26 - English

Stefan Mauss
	HIV-Infection Increases Cystatin C Concentrations Leading to an Underestimation of Glomerular Filtration Rate 2007-10-25 - English

Stefan Mauss
	Clinical Case 1 - Hepatitis B 2007-10-26 - English

Dirk Meyer-Olson
	Terminal Differentiation of HIV-specific T Cell Responses is Restricted to Distinct Clonotypes with Low CD57 Expression 2007-10-25 - English

Jean Michel Molina
	Prospective HLA-B*5701 Screening Significantly Reduces the Incidence of Abacavir Hypersensitivity Reactions (ABC HSR) in Patients Treated with ABC-Containing HAART 2007-10-25 - English

Jean Michel Molina
	HIV-1 Genotypic Resistance during Intermittent Antiretroviral Therapy and its Impact on CD4 Cell Counts and Antiviral Response. A Substudy of the ANRS 106 Window Trial 2007-10-25 - English

Graeme Moyle
	Continuation of BID Boosted PI vs Switch to Once-daily ATV/RTV for the Management of Lipodystrophy: 24-Week Interim Analysis of Metabolic and Inflammatory Parameters of the 96-Week Multicenter, Open-label, Randomised, Prospective Real Study 2007-10-25 - English

Sandra Mueller
	Protease Inhibitor Resistance Mutations Influence Recognition of Protease by HIV-1-Specific CTL 2007-10-25 - English

Cristina Mussini
	Patient case: 2nd failure to ARV therapy 2007-10-26 - English

O

Nicoletta Orchi
	Early and Late Newly Diagnosed HIV Infections 2007-10-25 - English

P

Giuseppe Pantaleo
	HIV Vaccines: State-of-the-art 2007-10-26 - English